EA202090177A1 - Стабильные каннабиноидные композиции - Google Patents

Стабильные каннабиноидные композиции

Info

Publication number
EA202090177A1
EA202090177A1 EA202090177A EA202090177A EA202090177A1 EA 202090177 A1 EA202090177 A1 EA 202090177A1 EA 202090177 A EA202090177 A EA 202090177A EA 202090177 A EA202090177 A EA 202090177A EA 202090177 A1 EA202090177 A1 EA 202090177A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cannabinoid
cannabinoid compositions
stable cannabinoid
stable
composition
Prior art date
Application number
EA202090177A
Other languages
English (en)
Inventor
Ильзе Кнёллер
Томас Зовик
Original Assignee
Сино-Джерман М Энд А Сервиз Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сино-Джерман М Энд А Сервиз Гмбх filed Critical Сино-Джерман М Энд А Сервиз Гмбх
Publication of EA202090177A1 publication Critical patent/EA202090177A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Композиция, содержащая каннабиноид, в частности фитоканнабиноид или синтетический каннабиноид, где каннабиноид стабилизирован против окисления и/или фотохимического разложения, отличающаяся тем, что композиция содержит мицеллярный раствор композитных мицелл в водном растворе, где композитные мицеллы инкапсулируют каннабиноид.
EA202090177A 2017-07-07 2018-07-06 Стабильные каннабиноидные композиции EA202090177A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17180380.2A EP3424493A1 (en) 2017-07-07 2017-07-07 Stable cannabinoid compositions
PCT/EP2018/068452 WO2019008179A1 (en) 2017-07-07 2018-07-06 STABLE CANNABINOID COMPOSITIONS

Publications (1)

Publication Number Publication Date
EA202090177A1 true EA202090177A1 (ru) 2020-06-05

Family

ID=59315425

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202090177A EA202090177A1 (ru) 2017-07-07 2018-07-06 Стабильные каннабиноидные композиции

Country Status (10)

Country Link
US (1) US11752126B2 (ru)
EP (2) EP3424493A1 (ru)
JP (1) JP7186222B2 (ru)
KR (1) KR102680507B1 (ru)
CN (2) CN115120558A (ru)
AU (1) AU2018296679B2 (ru)
CA (1) CA3076750A1 (ru)
EA (1) EA202090177A1 (ru)
IL (1) IL271892B2 (ru)
WO (1) WO2019008179A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112915121A (zh) * 2019-12-06 2021-06-08 汉义生物科技（北京）有限公司 一种***素纳米胶束制剂及其制备方法
EP4275694A1 (de) 2022-05-13 2023-11-15 Solmic Biotech GmbH Verwendung von solubilisaten in erzeugnissen zur topischen anwendung
DE202022000150U1 (de) 2022-01-20 2022-07-07 Solmic Bio Tech Gmbh Maske für medizinische oder kosmetische Zwecke mit mizellierten Extrakten
WO2023139101A1 (de) 2022-01-20 2023-07-27 Solmic Biotech GmbH Maske für medizinische oder kosmetische zwecke mit mizellierten extrakten

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995025504A1 (en) 1994-03-18 1995-09-28 Pharmavene, Inc. Emulsified drug delivery systems
JP2003500368A (ja) * 1999-05-24 2003-01-07 ソーナス ファーマシューティカルス，インコーポレイテッド 溶解度が不十分な薬剤のためのエマルジョンビヒクル
US20030236236A1 (en) 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
JP2005523295A (ja) * 2002-03-01 2005-08-04 ノバガリ、ファルマ、エスアー 難溶性薬剤の自己乳化型薬物送達システム
US20080045559A1 (en) * 2003-10-29 2008-02-21 Sonus Pharmaceuticals, Inc. Tocopherol-modified therapeutic drug compounds
US20100235972A1 (en) 2005-07-28 2010-09-23 Guasch Michael N Fuel repellent compositions, fabrics and articles
US7402325B2 (en) * 2005-07-28 2008-07-22 Phoenix Biotechnology, Inc. Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander
WO2008046905A1 (en) * 2006-10-20 2008-04-24 Solvay Pharmaceuticals B.V. Micellar nanoparticles of chemical substances
AR063330A1 (es) * 2006-10-20 2009-01-21 Solvay Pharm Bv Nanoparticulas micelares incrustadas
ES2622582T3 (es) * 2008-10-31 2017-07-06 University Of Mississippi Proceso para la preparación de ésteres de delta-9-THC-aminoácido
US20120088829A1 (en) * 2010-09-29 2012-04-12 MyCell Holdings Limited Formulations of Ubiquinol and Resveratrol Esters
US8808734B2 (en) 2011-07-11 2014-08-19 Full Spectrum Laboratories Limited Cannabinoid formulations
WO2014165672A1 (en) * 2013-04-06 2014-10-09 Igdrasol, Inc. Nanoparticle therapeutic agents, their formulations, and methods of their use
US9861611B2 (en) * 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same

Also Published As

Publication number Publication date
AU2018296679B2 (en) 2024-07-25
US20200237713A1 (en) 2020-07-30
CN115120558A (zh) 2022-09-30
JP7186222B2 (ja) 2022-12-08
US11752126B2 (en) 2023-09-12
WO2019008179A1 (en) 2019-01-10
CA3076750A1 (en) 2019-01-10
JP2020527170A (ja) 2020-09-03
AU2018296679A1 (en) 2020-02-20
IL271892B1 (en) 2023-04-01
KR102680507B1 (ko) 2024-07-01
IL271892B2 (en) 2023-08-01
EP3675825A1 (en) 2020-07-08
CN111246844A (zh) 2020-06-05
KR20200037247A (ko) 2020-04-08
EP3424493A1 (en) 2019-01-09
IL271892A (en) 2020-02-27

Similar Documents

Publication Publication Date Title
EA202090173A1 (ru) Стабильные каннабиноидные композиции
EA202090177A1 (ru) Стабильные каннабиноидные композиции
EA201992019A1 (ru) Съедобные и биоразлагаемые столовые приборы
MX2017011308A (es) Composiciones acondicionadoras para el cabello con microcápsulas.
EA201991798A1 (ru) Стабильные при хранении составы
MX2020006596A (es) Hidroxiisoxazolinas y derivados de estos.
MY192425A (en) Polymorphs
MX2017011309A (es) Composiciones acondicionadoras para el cabello con microcápsulas.
EA201791749A1 (ru) Инкапсуляция высокоэффективных активных агентов
MX2019013250A (es) 2,3,7-trimetiloct-6-enil acetato y 3,7-dimetil-2-metilen-oct-6-eni l acetato y derivados de estos y su uso como sustancias quimicas aromaticas.
CL2019002516A1 (es) Composiciones cosméticas para el cuidado de la piel.
PH12020500055A1 (en) A personal care composition
PH12016502386A1 (en) Oral care compositions
EA032472B9 (ru) Композиция для укладки волос
MX2017013278A (es) Odorante osmanthus.
EA202091456A1 (ru) Мононитрат моноацетата пропандиола
MX2020010159A (es) Composiciones de creatina y/o creatinina y metodos relacionados.
MX2021004804A (es) Compuestos organolepticos novedosos.
MX2021004581A (es) Composiciones acuosas que comprenden omega nitrooxi-1-alcanoles.
MX2020003261A (es) Odorizante ambar.
PL417588A1 (pl) Mieszanina antyutleniająca
MX2017016814A (es) 2,4,7-trimetiloct-6-en-1-ol como ingrediente de fragancia.
MX2015005523A (es) Novedoso compuesto organoleptico.
MX2018008731A (es) Compuestos organolepticos novedosos.
MX2020006331A (es) Mezclas estables al almacenamiento.